Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | KMI | ENB |
|---|---|---|
| Price | $31.30 | $47.47 |
| Change today | ▼ 0.24% | ▼ 0.80% |
| Market cap | $69.69B | $105.79B |
| Return, 3 months | -3.1% | -11.8% |
| Return, year to date | +17.1% | +7.5% |
| Return, 1 year | +17.0% | +6.4% |
| P/E (TTM) | 20.2 | 25.7 |
| P/B | 2.2 | 2.5 |
| P/E percentile vs own 5y | 44th | 75th |
| Dividend yield | 3.75% | 5.68% |
| Revenue growth (YoY, latest qtr) | +10.8% | +97.1% |
| Net profit growth (YoY) | +20.5% | -32.4% |
| Gross margin | 52.8% | 25.7% |
| Operating margin | 29.0% | 13.6% |
| Net margin | 19.2% | 6.8% |
| Return on equity | 11.1% | 9.7% |
| Analyst target vs. price | +16.2% | +21.4% |
| Analyst buy share | 46% | 57% |
| RSI (14) | 53 | 38 |
| 30-day volatility | 23.8% | 19.0% |
| Max drawdown, 1 year | -10.1% | -15.4% |
| Trend read | Leaning bullish | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.